Novonesis AS

Director's Dealing • Feb 5, 2013

February 5, 2013

In accordance with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B.

Name	Thomas Videbæk
Relation/category of close relation	EVP BioBusiness
Trading date	February 4, 2013
Character of transaction	Exercise of options (purchase of shares)
Volume of transaction buy(+)/ sell (-)	+118,295
Value of transaction (DKK)	10,480,937

Name	Benny D. Loft
Relation/category of close relation	EVP and CFO
Trading date	February 5, 2013
Character of transaction	Exercise of options (purchase of shares)
Volume of transaction buy(+)/ sell (-)	+60,000
Value of transaction (DKK)	5,316,000

Name	Per Falholt
Relation/category of close relation	EVP and CSO
Trading date	February 5, 2013
Character of transaction	Exercise of options (purchase of shares)
Volume of transaction buy(+)/ sell (-)	+124,220
Value of transaction (DKK)	9,689,160

Contact persons:

Press and media: Investor relations: René Tronborg (Europe) Tel. (mobile): +45 3077 2274

Paige Donnelly (USA) Tel. (mobile): +1 919 218 4501

Maarit Pokkinen Tel. (mobile): +45 3077 8682

Martin Riise Tel. (mobile): +45 3077 0738

Thomas Bomhoff (USA) Tel. (mobile): +1 919 649 2565

Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources. Read more at www.novozymes.com.

Krogshoejvej 36 2880 Bagsvaerd Denmark

Telephone: +45 4446 0000 Email: novozymesIR@novozymes.com Internet: www.novozymes.com